139 related articles for article (PubMed ID: 36974959)
21. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency.
Sahu PK; Mohapatra PK; Rajani DP; Raval MK
Curr Comput Aided Drug Des; 2020; 16(5):523-529. PubMed ID: 31654517
[TBL] [Abstract][Full Text] [Related]
22. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI
Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762
[TBL] [Abstract][Full Text] [Related]
23. Freezing the Dynamic Gap for Selectivity: Motion-Based Design of Inhibitors of the Shikimate Kinase Enzyme.
Prado V; Lence E; Thompson P; Hawkins AR; González-Bello C
Chemistry; 2016 Dec; 22(50):17988-18000. PubMed ID: 27699905
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C-δ inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase.
Pandey S; Chatterjee A; Jaiswal S; Kumar S; Ramachandran R; Srivastava KK
Biochem Biophys Res Commun; 2016 Sep; 478(2):721-6. PubMed ID: 27498028
[TBL] [Abstract][Full Text] [Related]
25. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
Filgueira de Azevedo W; Canduri F; Simões de Oliveira J; Basso LA; Palma MS; Pereira JH; Santos DS
Biochem Biophys Res Commun; 2002 Jul; 295(1):142-8. PubMed ID: 12083781
[TBL] [Abstract][Full Text] [Related]
26. Recombinant AroL-Catalyzed Phosphorylation for the Efficient Synthesis of Shikimic Acid 3-Phosphate.
Schoenenberger B; Wszolek A; Meier R; Brundiek H; Obkircher M; Wohlgemuth R
Biotechnol J; 2018 Aug; 13(8):e1700529. PubMed ID: 29697210
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for shikimate-binding specificity of Helicobacter pylori shikimate kinase.
Cheng WC; Chang YN; Wang WC
J Bacteriol; 2005 Dec; 187(23):8156-63. PubMed ID: 16291688
[TBL] [Abstract][Full Text] [Related]
28. Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids.
Simithy J; Fuanta NR; Alturki M; Hobrath JV; Wahba AE; Pina I; Rath J; Hamann MT; DeRuiter J; Goodwin DC; Calderón AI
Biochemistry; 2018 Aug; 57(32):4923-4933. PubMed ID: 30063132
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM
J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
[TBL] [Abstract][Full Text] [Related]
30. Understanding the structure, activity and inhibition of chorismate synthase from Mycobacterium tuberculosis.
Arcuri HA; Palma MS
Curr Med Chem; 2011; 18(9):1311-7. PubMed ID: 21366532
[TBL] [Abstract][Full Text] [Related]
31. Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials.
Gordon S; Simithy J; Goodwin DC; Calderón AI
Perspect Medicin Chem; 2015; 7():9-20. PubMed ID: 25861218
[TBL] [Abstract][Full Text] [Related]
32. A multifaceted approach to identify non-specific enzyme inhibition: Application to Mycobacterium tuberculosis shikimate kinase.
Alturki MS; Fuanta NR; Jarrard MA; Hobrath JV; Goodwin DC; Rants'o TA; Calderón AI
Bioorg Med Chem Lett; 2018 Feb; 28(4):802-808. PubMed ID: 29366649
[TBL] [Abstract][Full Text] [Related]
33. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of phosphoryl transfer catalyzed by shikimate kinase from Mycobacterium tuberculosis.
Hartmann MD; Bourenkov GP; Oberschall A; Strizhov N; Bartunik HD
J Mol Biol; 2006 Dec; 364(3):411-23. PubMed ID: 17020768
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.
Gan J; Gu Y; Li Y; Yan H; Ji X
Biochemistry; 2006 Jul; 45(28):8539-45. PubMed ID: 16834327
[TBL] [Abstract][Full Text] [Related]
36.
Nunes JES; Duque MA; de Freitas TF; Galina L; Timmers LFSM; Bizarro CV; Machado P; Basso LA; Ducati RG
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168746
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.
Schmidt MF; Korb O; Howard NI; Dias MV; Blundell TL; Abell C
ChemMedChem; 2013 Jan; 8(1):54-8. PubMed ID: 23169689
[TBL] [Abstract][Full Text] [Related]
38. Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pinto CA; Basso LA; Santos DS
Protein Expr Purif; 2001 Aug; 22(3):430-5. PubMed ID: 11483005
[TBL] [Abstract][Full Text] [Related]
39. Understanding the Catalytic Mechanism and the Nature of the Transition State of an Attractive Drug-Target Enzyme (Shikimate Kinase) by Quantum Mechanical/Molecular Mechanical (QM/MM) Studies.
Yao J; Wang X; Luo H; Gu P
Chemistry; 2017 Nov; 23(64):16380-16387. PubMed ID: 28925075
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Motion of Shikimate Kinase: Development of Competitive Inhibitors that Stabilize an Inactive Open Conformation of the Enzyme.
Prado V; Lence E; Maneiro M; Vázquez-Ucha JC; Beceiro A; Thompson P; Hawkins AR; González-Bello C
J Med Chem; 2016 Jun; 59(11):5471-87. PubMed ID: 27191386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
